AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 47 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,000 | -83.3% | 202,937 | -52.4% | 0.00% | -83.3% |
| Q2 2022 | $72,000 | +1.4% | 426,119 | +243.3% | 0.01% | -14.3% |
| Q4 2021 | $71,000 | +273.7% | 124,124 | +1013.1% | 0.01% | +250.0% |
| Q2 2021 | $19,000 | +90.0% | 11,151 | -33.9% | 0.00% | +100.0% |
| Q4 2019 | $10,000 | -33.3% | 16,860 | -43.6% | 0.00% | 0.0% |
| Q3 2019 | $15,000 | +25.0% | 29,885 | -5.9% | 0.00% | 0.0% |
| Q2 2019 | $12,000 | +9.1% | 31,755 | +61.6% | 0.00% | 0.0% |
| Q1 2019 | $11,000 | 0.0% | 19,648 | -7.7% | 0.00% | 0.0% |
| Q3 2018 | $11,000 | -97.1% | 21,281 | -77.0% | 0.00% | -95.0% |
| Q4 2017 | $376,000 | +6166.7% | 92,344 | +787.5% | 0.02% | – |
| Q3 2017 | $6,000 | – | 10,405 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shilanski & Associates, Inc. | 937,237 | $57,000 | 0.02% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $57,000 | 0.02% |
| CVA Family Office, LLC | 1,137,920 | $69,000 | 0.02% |
| Cypress Capital Management LLC (WY) | 140,925 | $9,000 | 0.01% |
| Helen Stephens Group, LLC | 117,222 | $7,000 | 0.01% |
| COURIER CAPITAL LLC | 540,056 | $33,000 | 0.00% |
| NORTHCAPE WEALTH MANAGEMENT, LLC | 98,000 | $6,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 10,000 | $1,000 | 0.00% |
| Western Wealth Management, LLC | 352,950 | $11,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 606,800 | $37,000 | 0.00% |